Streetbeat News

Stock Prices

DXCM

HBAN

LHX

LUV

Top Wall Street analysts have downgraded several notable stocks, including L3Harris Technologies, Huntington Bancshares, Southwest Airlines, Brunswick Corporation, and DexCom. These downgrades come with adjusted price targets, reflecting changes in analyst sentiment.

Portfolio Pulse from Avi Kapoor

July 26, 2024 | 12:04 pm

GNTX

Gentex Corporation has revised its FY14 revenue outlook downward from the previous range of $2.45 billion - $2.55 billion to a new range of $2.40 billion - $2.50 billion, compared to the $2.45 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:04 pm

DXCM

Dexcom Inc. (NASDAQ:DXCM) shares plummeted nearly 39% in pre-market trading after the company lowered its full-year sales outlook for glucose monitoring devices. The revised revenue forecast for 2024 is now between $4 billion and $4.05 billion, down from the previous estimate of $4.2 billion to $4.35 billion. The forecast cut is attributed to fewer new customers, lower revenue per customer, and higher rebates due to changes in reimbursement methods by large health plans. Despite these challenges, CEO Kevin Sayer remains confident in the company's long-term targets for 2025.

Portfolio Pulse from Benzinga Neuro

July 26, 2024 | 12:03 pm

GENE

Genetic Technologies Limited (NASDAQ: GENE) is transitioning to a capital light operating model to reduce costs and focus on sales growth in the US. The company will outsource operations and has secured a short-term $800,000 loan to fund working capital. EasyDNA sales are growing, reaching $7M.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:03 pm

BAH

Booz Allen Hamilton Holding Corp (NYSE:BAH) reported fiscal Q1 adjusted EPS of $1.38, missing the analyst consensus estimate of $1.52, leading to a 7.44% drop in stock price. Despite beating sales estimates and showing strong backlog growth, the stock declined due to the EPS miss.

Portfolio Pulse from Anusuya Lahiri

July 26, 2024 | 12:03 pm

PAPL

RCG

TMRC

Insiders have been buying shares of Pineapple Financial Inc. (NYSE:PAPL), Texas Mineral Resources Corp. (OTC:TMRC), and RENN Fund, Inc. (NYSE:RCG). This insider activity can be a signal of confidence in the companies' prospects.

Portfolio Pulse from Avi Kapoor

July 26, 2024 | 12:02 pm

GNTX

Gentex (NASDAQ:GNTX) reported Q2 earnings of $0.37 per share, missing the analyst estimate of $0.52 by 28.85%. Sales were $572.93M, also below the $620.04M estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:02 pm

NVCR

Over the past three months, four analysts have shared their evaluations of NovoCure (NASDAQ:NVCR), revealing a range of sentiments from bullish to bearish. The average 12-month price target has increased by 6.69% to $22.0. Analysts have adjusted their ratings and price targets, reflecting their responses to recent developments. NovoCure's financial performance shows significant revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 12:01 pm

ETHA

ETHE

GBTC

IBIT

Bitcoin has rebounded to $67,000, driven by Bitcoin ETFs gaining traction, while Ethereum ETFs face headwinds with significant outflows. Grayscale Ethereum Trust (ETHE) saw a net outflow of $346 million, while BlackRock's Ethereum ETF (ETHA) attracted $70.9289 million. Bitcoin spot ETFs recorded a net inflow of $31.1571 million, with BlackRock's Bitcoin ETF (IBIT) seeing substantial inflows.

Portfolio Pulse from Murtuza Merchant

July 26, 2024 | 12:01 pm

NTRA

Natera has announced a study published in the Journal of Clinical Oncology that highlights the high accuracy of its Signatera test for the surveillance of Merkel Cell Carcinoma patients. The study suggests that the test could potentially reduce the frequency of surveillance imaging.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:01 pm